Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 20.71%2.31B | 8.61%1.91B | -13.77%1.76B | 26.81%2.04B | -15.41%1.61B | -11.15%1.91B | 62.74%2.14B | 89.77%1.32B | 5.52%694.3M | -9.62%658M |
| Revenue from customers | 18.90%2.36B | 9.99%1.98B | -10.67%1.8B | 24.20%2.02B | -15.10%1.62B | -12.22%1.91B | 61.38%2.18B | 99.62%1.35B | 5.36%676.6M | -10.83%642.2M |
| Other cash income from operating activities | 31.73%-46.7M | -71.00%-68.4M | -252.09%-40M | 307.09%26.3M | -60.76%-12.7M | 77.62%-7.9M | -6.97%-35.3M | -286.44%-33M | 12.03%17.7M | 102.56%15.8M |
| Cash paid | -9.15%-1.08B | -41.32%-990.2M | 0.11%-700.7M | -1.29%-701.5M | 9.07%-692.6M | 19.65%-761.7M | -49.74%-948M | -67.49%-633.1M | 8.12%-378M | 3.97%-411.4M |
| Payments to suppliers for goods and services | -9.15%-1.08B | -41.32%-990.2M | 0.11%-700.7M | -1.29%-701.5M | 9.07%-692.6M | 19.65%-761.7M | -49.74%-948M | -67.49%-633.1M | 8.12%-378M | 3.97%-411.4M |
| Direct interest paid | -8.33%-41.6M | -186.57%-38.4M | -41.05%-13.4M | -46.15%-9.5M | 9.72%-6.5M | 76.85%-7.2M | -95.60%-31.1M | -93.90%-15.9M | 49.07%-8.2M | -106.41%-16.1M |
| Direct interest received | 16.67%9.8M | 100.00%8.4M | 950.00%4.2M | 100.00%400K | -90.91%200K | -46.34%2.2M | -51.19%4.1M | 52.73%8.4M | 52.78%5.5M | -67.86%3.6M |
| Direct tax refund paid | 45.48%-65.2M | 3.31%-119.6M | -12.56%-123.7M | 28.12%-109.9M | 42.24%-152.9M | -101.91%-264.7M | -829.79%-131.1M | -285.53%-14.1M | 1,185.71%7.6M | 99.06%-700K |
| Operating cash flow | 46.30%1.13B | -16.64%774.1M | -24.08%928.6M | 60.99%1.22B | -13.06%759.8M | -15.83%873.9M | 56.61%1.04B | 106.38%662.9M | 37.62%321.2M | 2.14%233.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 26.81%-792.1M | 7.48%-1.08B | -30.29%-1.17B | -18.47%-897.8M | 15.73%-757.8M | -379.32%-899.2M | 89.16%-187.6M | -1,022.37%-1.73B | -323.63%-154.2M | 91.77%-36.4M |
| Capital expenditure reported | 50.53%-79.3M | -15.99%-160.3M | -24.39%-138.2M | 20.30%-111.1M | 47.61%-139.4M | -172.64%-266.1M | -8.32%-97.6M | -81.29%-90.1M | 9.80%-49.7M | 56.99%-55.1M |
| Net PPE purchase and sale | 23.37%-711.9M | 9.44%-929M | -28.90%-1.03B | -50.07%-795.8M | 18.91%-530.3M | -71.34%-654M | -67.41%-381.7M | -109.17%-228M | 32.13%-109M | 48.03%-160.6M |
| Net intangibles purchas and sale | 75.68%-900K | 42.19%-3.7M | -16.36%-6.4M | -41.03%-5.5M | ---3.9M | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---84.2M | ---- | ---- | -6,444.98%-1.45B | -87.42%22.9M | --182M |
| Net investment purchase and sale | ---- | 1,442.86%10.8M | -30.00%700K | --1M | ---- | -96.61%8.9M | 676.33%262.4M | 308.64%33.8M | ---16.2M | ---- |
| Net other investing changes | ---- | ---- | ---- | --13.6M | ---- | -59.04%12M | 343.94%29.3M | 400.00%6.6M | 18.52%-2.2M | 48.08%-2.7M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 26.81%-792.1M | 7.48%-1.08B | -30.29%-1.17B | -18.47%-897.8M | 15.73%-757.8M | -379.32%-899.2M | 89.16%-187.6M | -1,022.37%-1.73B | -323.63%-154.2M | 91.77%-36.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -230.58%-340.3M | 26.81%260.6M | 203.01%205.5M | -1,050.00%-199.5M | 153.30%21M | 96.04%-39.4M | -196.49%-994M | 5,729.51%1.03B | 89.15%-18.3M | -487.80%-168.7M |
| Net issuance payments of debt | -158.11%-215M | 25.42%370M | 447.06%295M | -173.91%-85M | 91.67%115M | 106.32%60M | -218.75%-950M | --800M | ---- | ---165.2M |
| Net common stock issuance | 50.00%-300K | 0.00%-600K | 40.00%-600K | 82.46%-1M | -470.00%-5.7M | ---1M | ---- | --296.1M | ---- | ---- |
| Cash dividends paid | -25.11%-114.1M | -33.33%-91.2M | -50.00%-68.4M | 0.00%-45.6M | 0.00%-45.6M | -0.22%-45.6M | -9.64%-45.5M | -107.50%-41.5M | -284.62%-20M | 82.37%-5.2M |
| Net other financing activities | 69.03%-10.9M | 15.79%-35.2M | 69.44%-41.8M | -59.81%-136.8M | 20.00%-85.6M | -7,233.33%-107M | 106.15%1.5M | -1,535.29%-24.4M | 0.00%1.7M | 112.50%1.7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -230.58%-340.3M | 26.81%260.6M | 203.01%205.5M | -1,050.00%-199.5M | 153.30%21M | 96.04%-39.4M | -196.49%-994M | 5,729.51%1.03B | 89.15%-18.3M | -487.80%-168.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -21.43%172M | -13.99%218.9M | 100.87%254.5M | 15.29%126.7M | -36.07%109.9M | -44.76%171.9M | -10.57%311.2M | 74.79%348M | 16.98%199.1M | -58.62%170.2M |
| Current changes in cash | 100.21%100K | -33.43%-47.5M | -128.28%-35.6M | 447.39%125.9M | 135.55%23M | 54.88%-64.7M | -281.38%-143.4M | -125.29%-37.6M | 425.44%148.7M | 111.67%28.3M |
| Effect of exchange rate changes | -83.33%100K | --600K | ---- | 130.65%1.9M | -329.63%-6.2M | -34.15%2.7M | 412.50%4.1M | 300.00%800K | -66.67%200K | -57.14%600K |
| End cash Position | 0.12%172.2M | -21.43%172M | -13.99%218.9M | 100.87%254.5M | 15.29%126.7M | -36.07%109.9M | -44.76%171.9M | -10.57%311.2M | 74.79%348M | 16.98%199.1M |
| Free cash from | 206.59%339.9M | -31.78%-318.9M | -177.96%-242M | 260.09%310.4M | 286.58%86.2M | -108.27%-46.2M | 63.04%558.9M | 112.79%342.8M | 810.17%161.1M | 108.47%17.7M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |